- January 12, 2020
- Category: Healthcare and LifeSciences, Medical Device and Equipment
Global Cardiac Pacemakers Market Size study, by Product (Implantable Cardiac Pacemaker, External Cardiac Pacemaker), by End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Others) and Regional Forecasts 2020-2026
Chapter 1. Executive Summary 1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Million) 1.2.1. Cardiac Pacemakers Market, by Region, 2018-2026 (USD Million) 1.2.2. Cardiac Pacemakers Market, by Product, 2018-2026 (USD Million) 1.2.3. Cardiac Pacemakers Market, by End-user, 2018-2026 (USD Million) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Cardiac Pacemakers Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Cardiac Pacemakers Market Dynamics 3.1. Cardiac Pacemakers Market Impact Analysis (2018-2026) 3.1.1. Market Drivers 3.1.2. Market Challenges 3.1.3. Market Opportunities Chapter 4. Global Cardiac Pacemakers Market Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economical 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion Chapter 5. Global Cardiac Pacemakers Market, by Product 5.1. Market Snapshot 5.2. Global Cardiac Pacemakers Market by Product, Performance - Potential Analysis 5.3. Global Cardiac Pacemakers Market Estimates & Forecasts by Product 2016-2026 (USD Million) 5.4. Cardiac Pacemakers Market, Sub Segment Analysis 5.4.1. Implantable Cardiac Pacemaker 5.4.2. External Cardiac Pacemaker Chapter 6. Global Cardiac Pacemakers Market, by End-user 6.1. Market Snapshot 6.2. Global Cardiac Pacemakers Market by End-user, Performance - Potential Analysis 6.3. Global Cardiac Pacemakers Market Estimates & Forecasts by End-user 2016-2026 (USD Million) 6.4. Cardiac Pacemakers Market, Sub Segment Analysis 6.4.1. Hospitals & Clinics 6.4.2. Ambulatory Surgical Centers 6.4.3. Others Chapter 7. Global Cardiac Pacemakers Market, Regional Analysis 7.1. Cardiac Pacemakers Market, Regional Market Snapshot 7.2. North America Cardiac Pacemakers Market 7.2.1. U.S. Cardiac Pacemakers Market 18.104.22.168. Product breakdown estimates & forecasts, 2016-2026 22.214.171.124. End-user breakdown estimates & forecasts, 2016-2026 7.2.2. Canada Cardiac Pacemakers Market 7.3. Europe Cardiac Pacemakers Market Snapshot 7.3.1. U.K. Cardiac Pacemakers Market 7.3.2. Germany Cardiac Pacemakers Market 7.3.3. Rest of Europe Cardiac Pacemakers Market 7.4. Asia-Pacific Cardiac Pacemakers Market Snapshot 7.4.1. China Cardiac Pacemakers Market 7.4.2. India Cardiac Pacemakers Market 7.4.3. Japan Cardiac Pacemakers Market 7.4.4. Rest of Asia Pacific Cardiac Pacemakers Market 7.5. Latin America Cardiac Pacemakers Market Snapshot 7.5.1. Brazil Cardiac Pacemakers Market 7.5.2. Mexico Cardiac Pacemakers Market 7.6. Rest of The World Cardiac Pacemakers Market Chapter 8. Competitive Intelligence 8.1. Top Market Strategies 8.2. Company Profiles 8.2.1. BIOTRONIK SE & Co. KG. 126.96.36.199. Key Information 188.8.131.52. Overview 184.108.40.206. Financial (Subject to Data Availability) 220.127.116.11. Product Summary 18.104.22.168. Recent Developments 8.2.2. Boston Scientific Corporation 8.2.3. Medtronic PLC 8.2.4. Abbott Laboratories 8.2.5. St. Jude Medical Inc. 8.2.6. LivaNova PLC. 8.2.7. Lepu Medical Technology Co., Ltd. 8.2.8. Osypka Medical, Inc. 8.2.9. Pacetronix 8.2.10. MEDICO SpA Chapter 9. Research Process 9.1. Research Process 9.1.1. Data Mining 9.1.2. Analysis 9.1.3. Market Estimation 9.1.4. Validation 9.1.5. Publishing 9.2. Research Attributes 9.3. Research Assumption
Global Cardiac Pacemakers Market is valued approximately USD 4167.4 million in 2019 and is anticipated to grow with a healthy growth rate of more than 3.0% over the forecast period 2020-2026. A cardiac pacemaker is a type of medical device used to control the cardiac rhythm by transmitting electrical impulses to the heart. The main purpose of this pacemaker is to maintain an adequate heart rate either because of the heart’s natural pacemaker is not quick enough, or there is a block in the electrical conduction system of heart. Recent pacemakers are superficially programmable and allow a cardiologist, especially a cardiac electrophysiologist to decide on the optimal pacing modes for the individual patients. Rise in incidences of cardiovascular diseases owing to growing elderly population, along with the several supportive government initiatives and non-government organizations funding are the few factors responsible for high CAGR of the market over the forecast period. According to the American Heart Association, the death occurrence due to cardiovascular diseases was about 17.6 million in 2016, and a number is expected to grow to over 23.6 million by 2030. Also, as per the Center for Disease Control and Prevention (CDC), about 610,000 die due to heart diseases in the United States every year. This, in turn, is expected to accelerate the demand for cardiac pacemakers, thus contributing to the growth of the global market. However, high cost of treatment and high rate of product recalls due to device malfunctioning are the few factors expected to limit the growth of the market over the forecast period of 2020-2026.
The regional analysis of global Cardiac Pacemakers market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising incidence of cardiovascular diseases, coupled with the presence of well-established healthcare infrastructure in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to rising investments by government and development of new and innovative pacemakers, along with the rapid economic growth in developing economies such as China and India.
Major market player included in this report are:
BIOTRONIK SE & Co. KG.
Boston Scientific Corporation
St. Jude Medical Inc.
Lepu Medical Technology Co., Ltd.
Osypka Medical, Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
Implantable Cardiac Pacemaker
External Cardiac Pacemaker
Hospitals & Clinics
Ambulatory Surgical Centers
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026
Target Audience of the Global Cardiac Pacemakers Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers